-
EIB Provides BioNTech with Debt Financing for COVID-19 Vaccine Development, Manufacturing
americanpharmaceuticalreview
June 23, 2020
The European Investment Bank (EIB) and BioNTech SE concluded a €100 million debt financing agreement to support the development of BNT162, the company’s COVID-19 vaccine program.
-
Thai trials of COVID-19 vaccine reach make-or-break stage
expresspharma
June 23, 2020
Thirteen monkeys were immunized and the next two weeks will be critical in determining whether researchers can proceed with further tests.
-
AstraZeneca commits to supply Europe with 400 million doses of COVID-19 vaccine candidate
europeanpharmaceuticalreview
June 22, 2020
AstraZeneca plans to produce up to 400 million doses of the University of Oxford’s COVID-19 vaccine candidate, with deliveries to begin by the end of the year.
-
PDS Biotech and Farmacore partner to develop Covid-19 vaccine
pharmaceutical-technology
June 19, 2020
US-based immunotherapy company PDS Biotechnology has partnered with Brazilian biotechnology firm Farmacore Biotechnology to jointly develop a Covid-19 vaccine.
-
No-one left behind: ensuring Covid-19 vaccines are effective in at-risk groups
pharmaceutical-technology
June 19, 2020
Despite being most at risk from Covid-19, older people and those with compromised immune systems are unlikely to reap much benefit from Covid-19 vaccines, which are the main way we can overcome the viral pandemic.
-
EDQM to provide COVID-19 vaccine developers free access to quality standards
europeanpharmaceuticalreview
June 18, 2020
The EDQM and European Pharmacopoeia have decided to share Ph. Eur. quality standards for COVID-19 vaccine developers to support their research.
-
UK funds human trials of Imperial College London’s COVID-19 vaccine research
expresspharma
June 17, 2020
Robin Shattock, a professor at Imperial’s department of infectious disease, said that rather than using a part of the virus, as many vaccines do, this potential vaccine uses synthetic strands of the virus’ genetic material - RNA - which are packaged ....
-
Daiichi Sankyo to develop Covid-19 vaccine candidate in Japan
pharmaceutical-technology
June 16, 2020
Japanese pharmaceutical company Daiichi Sankyo is set to develop a mRNA vaccine candidate to protect against Covid-19 infection in the country.
-
Jacobs to Retrofit AstraZeneca’s Mfg. Facility for COVID-19 Vax
contractpharma
June 16, 2020
Will upgrade an existing idle Fill Line in West Chester, OH to support formulation, vial filling, visual inspection and packaging of the COVID-19 vaccine.
-
Moderna COVID-19 vaccine appears to clear safety hurdle in mouse study
expresspharma
June 16, 2020
Prior studies on a vaccine for SARS - a close cousin to the new virus that causes COVID-19 - suggests vaccines against this type of virus might have the unintended effect of causing more severe disease when the vaccinated person is later exposed to the ..